NASDAQ:PCSA

Heatwurx Q2 2026 Earnings Results & Report

Heatwurx logo
$1.56 -0.13 (-7.69%)
Closing price 11/20/2026 04:00 PM Eastern
Extended Trading
$1.56 -0.01 (-0.32%)
As of 11/20/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Heatwurx missed analyst earnings expectations in its Q2 2026 results, released August 14, 2026. The company reported EPS of -$1.19 versus the -$1.00 consensus estimate.

Earnings Announcement Details

Quarter
Q2 2026
Report Date
Time
Before Market Opens
Conference Call
7:00 AM ET

Heatwurx EPS Results

Actual EPS
-$1.19
Consensus EPS
-$1.00
Beat/Miss
Missed by -$0.19
One Year Ago EPS
N/A
EPS Beat Rate
3 of last 8 quarters

Heatwurx Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Earnings Documents

Heatwurx Q2 2026 Earnings FAQ

Heatwurx (NASDAQ:PCSA) reported earnings of -$1.19 per share for Q2 2026, missing the consensus estimate of -$1.00. The report was announced on Friday, August 14, 2026.

Heatwurx Earnings Headlines

Today's free pick (on me)
Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one lesser known company. With plans filed for 1,000,000 new satellites, that licensing fee could scale dramatically. Analyst Dylan says the stock could move by December 8th.tc pixel
See More Heatwurx Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Heatwurx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Heatwurx and other key companies, straight to your email.

About Heatwurx

Heatwurx (NASDAQ:PCSA) was an asphalt pavement repair technology company. It developed infrared-based equipment and repair methods intended to heat and reuse existing pavement, serving the road and pavement maintenance industry.

Heatwurx is a historical company name associated with the business now identified by Nasdaq ticker PCSA. The public company operates as Processa Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing treatments for serious medical conditions.

View Heatwurx Profile